PHR
Get informed when a big investor buys or sells
+ FollowUndervalued by 167.8% based on the discounted cash flow analysis.
| Market cap | $751.01 Million |
|---|---|
| Enterprise Value | $808.43 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.04 |
| Beta | 0.84 |
| Outstanding Shares | 60,944,962 |
| P/E Ratio | 79.83 |
|---|---|
| PEG | -30.05 |
| Price to Sales | 1.39 |
| Price to Book Ratio | 2.22 |
| Enterprise Value to Revenue | 1.63 |
| Enterprise Value to EBIT | -891.32 |
| Enterprise Value to Net Income | -83 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.37 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2916▼ 317.68% |
|---|---|
| Total Calls | 402,600▲ 389.78% |
| Total Puts | 117,400▼ 58.82% |
Holdings and activity of institutional investors.
| Ownership % | 97.31%▼ 0.97% |
|---|---|
| Total Invested | $657.12M▲ 32.61% |
| Investors Holding | 235▼ 18.00% |
No data
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimi...